NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration
Chunhong Cui,Yi Liu,Dennis Gerloff,Christian Rohde,Cornelius Pauli,Marcel Köhn,Danny Misiak,Thomas Oellerich,Schraga Schwartz,Lars-Henning Schmidt,Rainer Wiewrodt,Alessandro Marra,Ludger Hillejan,Frank Bartel,Claudia Wickenhauser,Stefan Hüttelmaier,Stefanie Göllner,Fengbiao Zhou,Bayram Edemir,Carsten Müller-Tidow
DOI: https://doi.org/10.1038/s41388-020-01570-y
IF: 8.756
2020-12-07
Oncogene
Abstract:Abstract Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide underlining the urgent need for new biomarkers and therapeutic targets for this disease. Long noncoding RNAs are critical players in NSCLC but the role of small RNA species is not well understood. In the present study, we investigated the role of H/ACA box small nucleolar RNAs (snoRNAs) and snoRNA-bound ribonucleoproteins (snoRNPs) in the tumorigenesis of NSCLC. H/ACA box snoRNPs including the NOP10 core protein were highly expressed in NSCLC. High levels of either NOP10 mRNA or protein were associated with poor prognosis in NSCLC patients. Loss of NOP10 and subsequent reduction of H/ACA box snoRNAs and rRNA pseudouridylation inhibited lung cancer cell growth, colony formation, migration, and invasion. A focused CRISPR/Cas9 snoRNA knockout screen revealed that genomic deletion of SNORA65, SNORA7A, and SNORA7B reduced proliferation of lung cancer cells. In line, high levels of SNORA65, SNORA7A, and SNORA7B were observed in primary lung cancer specimens with associated changes in rRNA pseudouridylation. Knockdown of either SNORA65 or SNORA7A/B inhibited growth and colony formation of NSCLC cell lines. Our data indicate that specific H/ACA box snoRNAs and snoRNA-associated proteins such as NOP10 have an oncogenic role in NSCLC providing new potential biomarkers and therapeutic targets for the disease.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology